Arachidonic acid: a common link in the biology of schizophrenia?

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Archives of General Psychiatry

• Publication date

  1994-08-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHPSYC.1994.03950080077012PMID 8042917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated plasma prostaglandin E2 levels in schizophrenia

  2005cited by this paper
• Brain pathology in schizophrenia: developmental or degenerative?

  1993cited by this paper
• Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

  1991cited by this paper
• Increased serum phospholipase A2 activity in schizophrenia: a replication study.

  1990cited by this paper
• Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

  1990cited by this paper
• Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells

  1989cited by this paper
• Free radicals mediate peroxidative damage in guinea pig hippocampus in vitro

  1989cited by this paper
• Fat consumption and schizophrenia

  1988cited by this paper
• Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia.

  1987cited by this paper
• Glutathione peroxidase and CT scan abnormalities in schizophrenia.

  1987cited by this paper
• Fatty acids in plasma and red cell membranes in normal humans

  1983cited by this paper

• Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: A pilot study

  2023cites this paper
• Uncovering complex disease subtypes by integrating clinical data and imputed transcriptome from genome-wide association studies: Applications in psychiatry and cardiovascular medicine

  2019cites this paper
• Integrating Clinical Data and Imputed Transcriptome from GWAS to Uncover Complex Disease Subtypes: Applications in Psychiatry and Cardiology.

  2019cites this paper
• Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms

  2017cites this paper
• A rapid UPLC-MS/MS assay for eicosanoids in human plasma: Application to evaluate niacin responsivity.

  2017cites this paper
• Phospholipid, arachidonate and eicosanoid signaling in schizophrenia

  2016cites this paper
• Randomized, Placebo-Controlled Clinical Trial of Omega-3 as Supplemental Treatment in Schizophrenia

  2014cites this paper
• Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review

  2014cites this paper
• Omega-3 fatty acids and schizophrenia: evidences and recommendations.

  2013cites this paper
• A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia

  2012cites this paper
• A Structure-Function Mechanism for Schizophrenia

  2012cites this paper
• Autistic disorder and phospholipids: A review.

  2011cites this paper
• Prostaglandins , Leukotrienes and Essential Fatty Acids

  2011cites this paper
• Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder.

  2010cites this paper
• Status and Potential Therapeutic Importance of n–3 Fatty Acids in Neuropsychiatric Disorders

  2009cites this paper
• Modulation of polyunsaturated fatty acid biosynthesis by antipsychotic medications: implications for the pathophysiology and treatment of schizophrenia

  2009cites this paper
• Altered red cell membrane compositions related to functional vitamin B12 deficiency manifested by elevated urine methylmalonic acid concentrations in patients with schizophrenia

  2008cites this paper
• Fatty acids and Schizophrenia

  2007cites this paper
• Ácidos grasos omega-3 y enfermedades neuropsiquiátricas

  2006cites this paper
• Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.

  2006cites this paper
• Alteration of polyunsaturated fatty acid status and metabolism in health and disease.

  2004cites this paper
• Membrane phospholipids and cytokine interaction in schizophrenia.

  2004cites this paper
• From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?

  2003cites this paper
• Relationship between the niacin skin flush response and essential fatty acids in schizophrenia.

  2003cites this paper
• Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.

  2003cites this paper
• Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum.

  2003cites this paper
• The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study.

  2003cites this paper
• Biochemical alterations of erythrocytes as an indicator of mental disorders: an overview.

  2003cites this paper
• Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder.

  2003cites this paper
• Essential fatty acids: theoretical aspects and treatment implications for schizophrenia and depression

  2002cites this paper
• Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling

  2002cites this paper
• Chapter 3 The lipid hypothesis of schizophrenia

  2002cites this paper
• Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples

  2001cites this paper
• Disorders of Phospholipid Metabolism in Schizophrenia, Affective Disorders, and Neurodegenerative Disorders

  2001cites this paper
• Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission

  2001cites this paper
• Acides gras polyinsaturés n-3, neurotransmission et fonctions cognitives

  2000cites this paper
• Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders?

  2000cites this paper
• Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia.

  2000cites this paper
• Obstetric factors, urbanization and psychosis.

  2000cites this paper
• Potential diagnostic aids for abnormal fatty acid metabolism in a range of neurodevelopmental disorders.

  2000cites this paper
• Neuroquímica da esquizofrenia : Neuroquímica da esquizofrenia : Neuroquímica da esquizofrenia : Neuroquímica da esquizofrenia : Neuroquímica da esquizofrenia : papel dos fosfolípides papel dos fosfolípides papel dos fosfolípides papel dos fosfolípides papel dos fosfolípides

  2000cites this paper
• Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin.

  2000cites this paper
• Neuroquímica da esquizofrenia: papel dos fosfolípides

  2000cites this paper
• Lipids and schizophrenia

  1999cites this paper
• The Membrane Phospholipid Concept of Schizophrenia

  1999cites this paper
• Schizophrenia: The illness that made us human

  1998cites this paper
• Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia.

  1998cites this paper
• The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

  1998cites this paper
• Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects.

  1998cites this paper
• Schizophrenia: the illness that made us human.

  1998cites this paper
• Niacin skin flush in schizophrenia: a preliminary report.

  1998cites this paper
• Fatty Acids, Phospholipids, and Schizophrenia

  1997cites this paper
• High levels of dietary arachidonic acid triglyceride exhibit no subchronic toxicity in rats

  1997cites this paper
• Arachidonic Acid, Neurotrauma, and Neurodegenerative Diseases

  1997cites this paper
• Heat stress lipids and schizophrenia.

  1996cites this paper
• Cultured skin fibroblasts as a cell model for investigating schizophrenia.

  1996cites this paper
• Omega‐3 fatty acid supplementation in schizophrenic patients

  1996cites this paper
• Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls.

  1996cites this paper
• Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation.

  1996cites this paper
• Free radical pathology in schizophrenia: a review.

  1996cites this paper
• Reduced susceptibility to oxidative damage of erythrocyte membranes from medicated schizophrenic patients.

  1996cites this paper
• Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

  1996cites this paper
• Free radical involvement in neuropsychiatric illnesses.

  1995cites this paper
• Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients.

  1995cites this paper